A lthough the annual stroke death rate in the United States fell 29.7% during the last decade, and although the actual number of stroke deaths declined 13.5% during the same period, stroke remains a leading cause of death and serious long-term disability in this country. 1 Medical complications are common in patients with stroke, 2 but the impact of these complications has not been well studied. The complications of pneumonia (PN), deep vein thrombosis (DVT), pulmonary embolism (PE), and urinary tract infection (UTI) after an acute ischemic stroke are recognized as negative indicators of the quality of stroke care, 3, 4 and acute myocardial infarction (AMI) is not uncommon after an acute ischemic stroke. 5 All of these complications are largely preventable or treatable and may adversely affect the patient's outcome and extend the length of stay (LOS). Even so, there have been few population-based estimates of these complications and very little on their recent trends. Prevention of venous thromboembolic disease (DVT and PE) and PN are a focus of several programs for improving the quality of stroke care, including The Joint Commission's Primary Stroke Center program, American Heart Association's Get With The Guidelines-Stroke program, and the Centers for Disease Control and Prevention's Paul Coverdell National Acute Stroke Registry. Additionally, in October 2008, the Centers for Medicare and Medicaid instituted efforts to reduce catheter-associated UTIs in hospitalized patients.
Recently, a need for initiating surveillance of noncommunicable disease at the national and global levels has been increasingly recognized (World Health Organization web site: www.who.int/ncd_surveillance/en/). 6 However, currently no comprehensive surveillance system is available to monitor changes in patient care. Previous experience with the development of surveillance systems in other areas at the national level shows that the standardized nationwide hospital discharge data sets and standardized definitions can be used for this purpose. 7 In the present report, we examined hospi-talizations of adults (age Ն18 years) whose primary diagnosis was ischemic stroke as revealed by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. The 3 primary objectives were to (1) examine trends in AMI, PN, DVT, PE, and UTI as secondary diagnoses, in-hospital mortality, and LOS; (2) investigate the associations of AMI, PN, DVT, PE, and UTI with in-hospital mortality; and (3) compare LOS for hospitalizations with and without AMI, PN, DVT, PE, and UTI diagnosis. We drew on the 1998 to 2007 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality. For this analysis, we have chosen to use the term "complications" for these secondary diagnoses rather than comorbid conditions, but we realize that we were not able to distinguish them as present on arrival or developing during the admission.
Methods

Data Sources
The NIS is a stratified, cross-sectional sample that includes approximately 20% of all community (nonfederal) hospital discharges in the United States. The NIS database collects yearly data from approximately 1000 hospitals stratified by region, location/teaching status, number of beds, and ownership and the sampling unit represents a hospitalization, not a person or patient (the same patient may be included in Ն2 hospitalizations). The NIS is the largest all-payer inpatient care database in the United States. The details of the NIS sampling design, data elements, and estimates can be found at the Healthcare Cost and Utilization Project web site (www.hcup-us.ahrq. gov/).
Study Variables
Complications were identified by searching the secondary diagnostic codes (ICD-9-CM codes) for AMI, PN, DVT, PE, and UTI (the detailed ICD-9-CM coding is presented in the Appendix to this article). In addition to medical complications, in-hospital mortality and LOS were also assessed in this analysis. Nine comorbidity conditions (congestive heart failure, peripheral vascular disease, hypertension, paralysis, other neurological disorders, chronic pulmonary disease, diabetes with chronic complications, renal failure, and coagulopathy) were chosen from the list of comorbidities proposed by the Agency for Healthcare Research and Quality based on the significance of associations with in-hospital mortality reported in the previous studies 8 and these conditions did not overlap with the complications focused on in this report. Furthermore, we examined the association between the outcome variables and the following demographic features: age (Ͻ65 years versus Ն65 years), sex (male versus female), payment type (Medicare, Medicaid, private, and other), and hospital location (urban versus rural).
Statistical Methods
The unit of analysis was the hospital discharge. To develop national estimates from our findings, we used discharge weights; which were developed to extrapolate NIS sample discharges to the total discharges. Five time intervals were selected in this study: The prevalence of medical complications (AMI, PN, DVT, PE, and UTI) as well as in-hospital mortality was assessed across 5 time intervals. Multiple logistic regression analyses were conducted to examine whether there was a linear trend across the 5 time periods in the prevalence of medical complications after adjusting for age, sex, payment type, and hospital location. To assess the changes over time in in-hospital mortality, multiple logistic regression modeling was used adjusting for age, sex, payment type, the 9 comorbidities mentioned, and hospital location as well as the complications of interest in this report. A linear regression model was used to assess the changes in LOS across the 5 time periods after adjusting for age, sex, payment type, and hospital locations. The orthogonal polynomial coefficients were obtained in both the logistic and linear regression models for testing the linear trend. In addition, we examined the changes in prevalence of medical complications and in-hospital mortality between 1998 to 1999 and 2006 to 2007 by using multiple logistic regression analysis after the adjustments described previously.
To evaluate the patient and hospital factors that might be associated with medical complications and in-hospital mortality, we applied the same logistic regression model within 1998 to 1999 and 2006 to 2007. Adjusted ORs and 95% CIs were obtained from the multiple logistic regression models. Lastly, we used t tests to assess the difference in LOS between hospitalizations with and without medical complications between 1998 to 1999 and 2006 to 2007. Because of the larger sample size, 2-tailed probability values Ͻ0.01 were considered to be significant throughout the analyses. All statistical analyses were performed with the statistical software package SUDAAN (Release 9.2; Research Triangle Institute, Research Park, NC) to account for the complex sample design. 
Results
During
Medical Complications
The prevalence of hospitalizations with a secondary diagnosis of PN did not change during the study period (Table 1) . In contrast, the prevalence of hospitalizations with a secondary diagnosis of AMI, DVT, PE, or UTI increased significantly across the study period (PϽ0.001). The prevalence of hospitalizations with at least 1 complication (AMI, PN, DVT, PE, or UTI) increased from 12.8% in 1998 to 1999 to 14 
In-Hospital Mortality
Overall, the in-hospital mortality rate decreased significantly across the study period after adjustment for age, sex, payer, hospital location, complications, and comorbidities (PϽ0.001). Using 1998 to 1999 as the referent, the adjusted OR for in-hospital mortality was 0.75 (95% CI: 0.72 to 0.79) Table 3 ) had significantly higher odds of in-hospital mortality than the reference group (private insurance). Additionally, hospitalizations in urban areas had significantly lower odds of in-hospital mortality than hospitalizations in rural areas (adjusted OR 0.8 in both 1998 to 1999 and 2006 to 2007).
All 5 complications except UTI in 2006 to 2007 were independent predictors of in-hospital mortality in the multivariable analysis in both time periods with PN, PE, and AMI being the strongest predictors of in-hospital mortality ( Table 3) . Table 1) . The probability value for trend was Ͻ0.001 after adjustment for age, sex, payment type, and hospital location. Univariate analyses found that LOS deceased significantly between the first and last time periods among hospital stays without AMI or PN or DVT or PE, stays with or without UTI, or stays with at least 1 complication and without any complication (Figure) . However, stays with complications of AMI, PN, DVT, or PE remained the same between these 2 time periods. The mean LOS with a complication was significantly longer than those without the complication in both 1998 to 1999 
Length of Stay
Discussion
Consistent with results from other studies, 9, 10 we found that in-hospital mortality for ischemic stroke decreased significantly during the period of study (1998 to 1999 to 2006 to 2007). Unfortunately, we found increasing trends in the prevalence of 4 of the 5 complications we examined with the largest increases observed for DVT and PE.
Among all the medical complications evaluated in this study, UTI was the most common, and estimates for this event were comparable to other studies. 11, 12 The nationwide prevalence of AMI, PN, DVT, PE, and UTI among hospitalizations with ischemic stroke has been reported by Qureshi and colleagues, 9 but it is difficult to compare their results with ours because of the differences in the ICD-9-CM codes used to identify the complications. Regardless, the increasing trends in the prevalence of DVT reported by Qureshi and coworkers were seen in our study as well. Moreover, the increasing trends we found in DVT and PE are parallel to *Statistically significant. Adjustments of 9 comorbidity conditions: congestive heart failure, peripheral vascular, hypertension, paralysis, other neurological disorders, chronic pulmonary disease, diabetes with chronic complications, renal failure, and coagulopathy.
trends reported in other studies as well as reports in other groups of hospitalized patients. 7, 13, 14 These trends may reflect a true increase in the prevalence of these conditions or they may indicate improved detection due to the increasing availability of new and improved diagnostic procedures. Finally, changes in hospital coding practices in the later years of the targeted analysis period compared with the earlier years could contribute to the trends reported by us.
Recommendations have been developed to improve the quality of acute stroke care by several professional and scientific organizations. 15, 16 For example, the guidelines of the American Heart Association Science Advisory and Coordinating Committee recommend early mobilization, general supportive care, and treatment of acute complications such as AMI, PN, and UTI and prevention of venous thromboembolic disease in patients with ischemic stroke. 15 Prophylactic lowdose subcutaneous heparin or low-molecular-weight heparins are recommended for patients with acute ischemic stroke with restricted mobility. 16 Currently, the extent to which preventive measures for DVT and PE among patients with ischemic stroke are implemented in the United States is not known. However, our results underline the importance of preventing venous thromboembolic disease and PE in these patients and the need to collect and evaluate information on the implementation of these preventive measurements using registries and other related clinical data sets.
We found that all 5 of the complications except UTI in 2006 to 2007 were significant predictors of in-hospital mortality after adjustment of comorbidities with AMI, PN, and PE the strongest predicators. Several studies have found a significant association between both PN and PE and early mortality (Յ30 days) among patients hospitalized for acute stroke. [17] [18] [19] In fact, the German Stroke Registers study group found that PN was the complication with the highest attributable proportion of deaths in the entire stroke population, accounting for 31% of all deaths. 19 Although stroke as a serious complication among patients with AMI has been documented, 20 -22 few studies have focused on associations between in-hospital AMI and outcomes among patients with stroke. A recent study published by the Canadian Stroke Network, however, found that AMI was an important medical complication after acute ischemic stroke and was independently associated with 1-year mortality or severe dependence at discharge. 5 We were unable to distinguish between early and late mortality in our study, but our results confirmed that AMI, PN, and PE are strong predictors of in-hospital mortality. In addition, although the overall LOS decreased significantly from 1998 to 1999 to 2006 to 2007, it remained the same among the hospitalizations with AMI, PN, DVT, or PE during this study period. Our study confirmed the findings that patients hospitalized with complications had significantly longer LOS than those without. 11, 12 These results suggest the longer LOS among hospitalizations with complications may contribute significantly to acute treatment cost. 23, 24 Future studies are needed to examine the impact of decreased LOS on cost, quality of care, and long-term outcomes among ischemic stroke hospitalizations without complications.
The results of this analysis should be interpreted in light of several limitations. First, the unit of the analysis was the hospital discharge, not the patient. We were unable to identify whether patients were admitted to the hospital multiple times in any 1-year period, and thus the results might be overestimated. Second, medical complications were identified by using ICD-9-CM codes abstracted from discharge records. Although any complication should be coded if this condition interferes with the patient management, 25 bias associated with coding is possible. Unavailability or inconsistent use of standardized diagnostic criteria for some conditions among physicians, differences in ICD-9-CM coding at the hospital level, and decreased likelihood of coding for nonthreatening conditions among patients with severe illness may contribute to this. 26 In addition, we were unable to identify if secondary conditions defined by ICD-9-CM codes were pre-existing or developing during the hospitalization. Currently, except for 4 states (California, New York, Florida, and Wisconsin), the Healthcare Cost and Utilization Project data did not include a present-on-admission indicator. Thus, the time of onset of secondary diagnoses cannot be established from this administrative data set and pre-existing conditions and complications cannot be distinguished. Third, although we used payment source as a proxy of socioeconomic status, a lack of information on race precluded us from assessing this confounder. Fourth, it is possible that an increase in discharge to a hospice could account for some decrease in in-hospital mortality. Early discharge to home, rehabilitation, or chronic care could account for the decrease of LOS. We were unable to examine the impact of discharge destination such as a hospice or rehabilitation on mortality and LOS due to lack of detailed information on discharge destination collected in Healthcare Cost and Utilization Project data. Finally, clinical (stroke severity, history of DVT, body mass index, use of oral contraceptives or estrogens, and so on) 27 and healthcare factors (anticoagulation therapy, long immobilization, recent major surgery, and so on) and their contribution to the trends could not be examined because of the absence of clinical details in our database.
In conclusion, given our findings on the 5 complications of interest, there is clearly a need for further investigation of the sociodemographic, clinical, and healthcare factors associated with these conditions during hospitalizations with ischemic stroke. Our results also underscore the need for continued efforts to reduce complications from acute stroke through active quality improvement programs. Additionally, these results suggest the need for further studies to investigate AMI as a complication of stroke hospitalizations. Finally, we believe that our results can be applied to extend surveillance for quality improvement initiatives at the state and hospital level as well as internationally and provide valuable information for comparisons across many settings.
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